Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease

• Helen Budworth,

  Affiliation Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America

  ⨯
• Faye R. Harris,

  Affiliation Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Paul Williams,

  Affiliation Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America

  ⨯
• Do Yup Lee,

  Affiliation Department of Bio and Fermentation Convergence Technology, Kookmin University, Seoul, Korea

  ⨯
• Amy Holt,

  Affiliation Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America

  ⨯
• Jens Pahnke,

  Affiliations Department of Neuropathology, University of Oslo, Oslo, Norway, LIED, University of Lübeck, Lübeck, Germany

  ⨯
• Bartosz Szczesny,

  Affiliation Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas, United States of America

  ⨯
• Karina Acevedo-Torres,

  Affiliations Puerto Rico Center for Inherited Diseases, University of Puerto Rico, San Juan, Puerto Rico, Department of Pharmacology and Toxicology, University of Puerto Rico, San Juan, Puerto Rico

  ⨯
• Sylvette Ayala-Peña,

  Affiliations Puerto Rico Center for Inherited Diseases, University of Puerto Rico, San Juan, Puerto Rico, Department of Pharmacology and Toxicology, University of Puerto Rico, San Juan, Puerto Rico

  ⨯
• Cynthia T. McMurray

  * E-mail: ctmcmurray@lbl.gov

  Affiliation Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America

  ⨯